MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma

Glioblastoma (GBM) is an incurable cancer, with mean post-diagnosis survival time of 14-16 months. Metagenomic analysis by The Cancer Genome Atlas (TCGA) program has identified microRNA-182-5p (miR-182-5p or miR-182) as the only miRNA associated with favorable disease prognosis and temozolomide (TMZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liqiang, Zhang, Xiaowei, Nan, Chengrui, Zhao, Zongmao, Ma, Shucheng, Li, Wenhua, Hu, Hongchao, Liang, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777723/
https://www.ncbi.nlm.nih.gov/pubmed/29383111
http://dx.doi.org/10.18632/oncotarget.21309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777723/
https://www.ncbi.nlm.nih.gov/pubmed/29383111
http://dx.doi.org/10.18632/oncotarget.21309

Ejemplares similares